Literature DB >> 2040287

Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria.

N Grankowski1, B Boldyreff, O G Issinger.   

Abstract

cDNA encoding the casein kinase II (CKII) subunits alpha and beta of human origin were expressed in Escherichia coli using expression vector pT7-7. Significant expression was obtained with E. coli BL21(DE3). The CKII subunits accounted for approximately 30% of the bacterial protein; however, most of the expressed proteins were produced in an insoluble form. The recombinant CKII alpha subunit was purified by DEAE-cellulose chromatography, followed by phosphocellulose and heparin-agarose chromatography. The recombinant CKII beta subunit was extracted from the insoluble pellet and purified in a single step on phosphocellulose. From 10 g bacterial cells, the yield of soluble protein was 12 mg alpha subunit and 5 mg beta subunit. SDS/PAGE analysis of the purified recombinant proteins indicated molecular masses of 42 kDa and 26 kDa for the alpha and beta subunits, respectively, in agreement with the molecular masses determined for the subunits of the native enzyme. The recombinant alpha subunit exhibited protein kinase activity which was greatest in the absence of monovalent ions. With increasing amounts of salt, alpha subunit kinase activity declined rapidly. Addition of the beta subunit led to maximum stimulation at a 1:1 ratio of both subunits. Using a synthetic peptide (RRRDDDSDDD) as a substrate, the maximum protein kinase stimulation observed was fourfold under the conditions used. The Km of the reconstituted enzyme for the synthetic peptide (80 microM) was comparable to the mammalian enzyme (40-60 microM), whereas the alpha subunit alone had a Km of 240 microM. After sucrose density gradient analysis, the reconstituted holoenzyme sedimented at the same position as the mammalian CKII holoenzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040287     DOI: 10.1111/j.1432-1033.1991.tb15982.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  54 in total

1.  Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

Authors:  M Kusk; R Ahmed; B Thomsen; C Bendixen; O G Issinger; B Boldyreff
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.

Authors:  J Roig; A Krehan; D Colomer; W Pyerin; E Itarte; M Plana
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Functional analysis of CK2beta-derived synthetic fragments.

Authors:  F Meggio; O Marin; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Protein kinase CK2 interacts with a multi-protein binding domain of p53.

Authors:  C Götz; P Scholtes; A Prowald; N Schuster; W Nastainczyk; M Montenarh
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Distinctive features of plant protein kinase CK2.

Authors:  M Riera; G Peracchia; M Pagès
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

6.  Characterization of CK2 holoenzyme variants with regard to crystallization.

Authors:  B Guerra; K Niefind; I Ermakowa; O G Issinger
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

7.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 8.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

9.  Activation of human topoisomerase I by protein kinase CK2.

Authors:  Barbara Kowalska-Loth; Agnieszka Girstun; Rafal Derlacz; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

10.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.